Next Science Ltd (NXS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 2.498x

Based on the latest financial reports, Next Science Ltd (NXS) has a cash flow conversion efficiency ratio of 2.498x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.39 Million ≈ $-984.59K USD) by net assets (AU$-557.03K ≈ $-394.14K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NXS equity financing ratio to measure how much of total assets are equity-financed.

Next Science Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Next Science Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore Next Science Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Next Science Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Next Science Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Softing AG XETRA:SYT	0.015x
Aerodrome Group Ltd TA:ARDM	-0.198x
Ponni Sugars (Erode) Limited NSE:PONNIERODE	0.037x
Societe d Exploration Miniere Vior Inc V:VIO	0.001x
Hochschild Mining plc LSE:HOC	0.304x
Aciselsan Acipayam Seluloz Sanayi Ve Ticaret AS IS:ACSEL	0.026x
Shanghai Lingyun Industries Development Co Ltd SHG:900957	-0.002x
V-Tac Technology Co Ltd TWO:6229	-0.138x

Annual Cash Flow Conversion Efficiency for Next Science Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Next Science Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see NXS market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AU$3.44 Million ≈ $2.44 Million	AU$-7.96 Million ≈ $-5.63 Million	-2.313x	-96.95%
2023-12-31	AU$12.82 Million ≈ $9.07 Million	AU$-15.06 Million ≈ $-10.66 Million	-1.175x	-18.05%
2022-12-31	AU$11.85 Million ≈ $8.38 Million	AU$-11.79 Million ≈ $-8.34 Million	-0.995x	-29.22%
2021-12-31	AU$10.73 Million ≈ $7.59 Million	AU$-8.26 Million ≈ $-5.85 Million	-0.770x	-21.55%
2020-12-31	AU$18.80 Million ≈ $13.30 Million	AU$-11.91 Million ≈ $-8.42 Million	-0.633x	+1.67%
2019-12-31	AU$19.37 Million ≈ $13.71 Million	AU$-12.48 Million ≈ $-8.83 Million	-0.644x	-31.02%
2018-12-31	AU$23.74 Million ≈ $16.80 Million	AU$-11.67 Million ≈ $-8.26 Million	-0.492x	-1532.03%
2017-12-31	AU$3.61 Million ≈ $2.55 Million	AU$-108.77K ≈ $-76.96K	-0.030x	+98.28%
2016-12-31	AU$1.34 Million ≈ $948.25K	AU$-2.35 Million ≈ $-1.66 Million	-1.751x	--

About Next Science Ltd

AU:NXS Australia Drug Manufacturers - Specialty & Generic

Market Cap

$30.02 Million

AU$42.43 Million AUD

Market Cap Rank

#23758 Global

#914 in Australia

Share Price

AU$0.15

Change (1 day)

+0.00%

52-Week Range

AU$0.14 - AU$0.16

All Time High

AU$4.60